FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Mayne Pharma Carbidopa and Levodopa Tablets Recall

Carbidopa and Levodopa Tablets, USP 25 mg/250mg, 100 ct bottle, Rx Only, Mayne Pharma,…

Mayne Pharma Inc · Greenville, NC

Risk level
Class II
Reported by FDA
Mar 18, 2020
Recall ID
D-0998-2020
Check your lot numberHow we source this data

Summary

Mayne Pharma recalled Carbidopa and Levodopa Tablets starting Mar 2, 2020. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0998-2020 on Mar 18, 2020. Reason: Product Mix-Up: A foreign tablet was found in bottle. Status: Terminated.

Why it was recalled

Product Mix-Up: A foreign tablet was found in bottle.

Product description

Carbidopa and Levodopa Tablets, USP 25 mg/250mg, 100 ct bottle, Rx Only, Mayne Pharma, Greenville, NC 27834. NDC 51862-858-01

Lot numbers, UPCs & expiration codes

Lot: FG11514 Exp. 05/2021

Where it was sold

Distributed Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0998-2020
Classification
Class II
Status
Terminated
Recall initiated
Mar 2, 2020
FDA report date
Mar 18, 2020
Quantity
8274 100-count bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Mayne Pharma Inc

Original FDA data

Every field from FDA enforcement report D-0998-2020, exactly as published.

Show all FDA fields
City
Greenville
State
NC
Status
Terminated
Country
United States
Event ID
85125
Address
1240 Sugg Pkwy
Code information
Lot: FG11514 Exp. 05/2021
Postal code
27834-9006
Report date
Mar 18, 2020
Product type
Drugs
Recall number
D-0998-2020
Classification
Class II
Recalling firm
Mayne Pharma Inc
Product quantity
8274 100-count bottles
Termination date
Oct 28, 2021
Reason for recall
Product Mix-Up: A foreign tablet was found in bottle.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Carbidopa and Levodopa Tablets, USP 25 mg/250mg, 100 ct bottle, Rx Only, Mayne Pharma, Greenville, NC 27834. NDC 51862-858-01
Distribution pattern
Distributed Nationwide in the USA
Recall initiation date
Mar 2, 2020
Initial firm notification
Letter
Center classification date
Mar 9, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0998-2020, published Mar 18, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls